{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:26:55Z","timestamp":1773084415121,"version":"3.50.1"},"reference-count":297,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.peptides.2007.10.006","type":"journal-article","created":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T12:35:58Z","timestamp":1194525358000},"page":"2411-2434","source":"Crossref","is-referenced-by-count":42,"title":["From MIF-1 to endomorphin: The Tyr-MIF-1 family of peptides"],"prefix":"10.1016","volume":"28","author":[{"given":"Weihong","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abba J.","family":"Kastin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2007.10.006_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0143-4179(87)90074-6","article-title":"Influence of protease inhibitors on the antidepressant activity of oxytocin","volume":"10","author":"Arletti","year":"1987","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib2","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/00001756-199807130-00022","article-title":"Endomorphins have orexigenic and anxiolytic activities in mice","volume":"9","author":"Asakawa","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2007.10.006_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2007-978587","article-title":"Endomorphin-1, an endogenous mu-opioid receptor-selective agonist, stimulates oxygen consumption in mice","volume":"32","author":"Asakawa","year":"2000","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1019766602138","article-title":"Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages","volume":"26","author":"Azuma","year":"2002","journal-title":"Inflammation"},{"key":"10.1016\/j.peptides.2007.10.006_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-5728(01)00363-0","article-title":"Endomorphins 1 and 2 modulate chemotaxis, phagocytosis and superoxide anion production by microglia","volume":"119","author":"Azuma","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.peptides.2007.10.006_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-2478(00)00274-1","article-title":"Immunomodulation of the neutrophil respiratory burst by endomorphins 1 and 2","volume":"75","author":"Azuma","year":"2000","journal-title":"Immunol Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0091-3057(84)80077-5","article-title":"A brain-to-blood carrier-mediated transport system for small, N-tyrosinated peptides","volume":"21","author":"Banks","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0361-9230(85)90153-4","article-title":"Peptides and the blood\u2013brain barrier: lipophilicity as a predictor of permeability.","volume":"15","author":"Banks","year":"1985","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2042-7158.1988.tb05248.x","article-title":"Twenty-one hormones fail to inhibit the brain to blood transport system for Tyr-MIF-1 and the enkephalins in mice","volume":"40","author":"Banks","year":"1988","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0196-9781(94)90165-1","article-title":"Opposite direction of transport across the blood\u2013brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine","volume":"15","author":"Banks","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jnr.490350611","article-title":"Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1","volume":"35","author":"Banks","year":"1993","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib12","first-page":"E477","article-title":"Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood\u2013brain barrier","volume":"251","author":"Banks","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2007.10.006_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0892-0362(96)00128-6","article-title":"Perinatal treatment of rats with opiates affects the development of the blood\u2013brain barrier transport system PTS-1","volume":"18","author":"Banks","year":"1996","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.peptides.2007.10.006_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0196-9781(87)90078-7","article-title":"Tyr-MIF-1 and met-enkephalin share a saturable blood\u2013brain barrier transport system","volume":"8","author":"Banks","year":"1987","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0361-9230(90)90116-H","article-title":"Stereospecific transport of Tyr-MIF-1 across the blood\u2013brain barrier by peptide transport system-1","volume":"25","author":"Banks","year":"1990","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(75)90778-3","article-title":"Potentiation of levodopa effect by intravenous l-prolyl-l-leucyl-glycine amide in man","volume":"2","author":"Barbeau","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2007.10.006_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0091-3057(76)90322-1","article-title":"Influence of 3 short chain peptides (\u03b1-MSH, MSH\/ACTH 4-10, MIF- I) on dimensional attention","volume":"5","author":"Beckwith","year":"1976","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0196-9781(99)00090-X","article-title":"Tolerance and morphine-induced cross-tolerance are shown to Tyr-W-MIF-1 analgesia","volume":"20","author":"Bell","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0028-3908(84)90252-1","article-title":"Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats","volume":"23","author":"Bhargava","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.peptides.2007.10.006_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0024-3205(84)90204-2","article-title":"Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase","volume":"34","author":"Bhargava","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib21","first-page":"81","article-title":"Central actions of endomorphins: new endogenous opioids","volume":"41","author":"Bihm","year":"1998","journal-title":"Proc West Pharmacol Soc"},{"key":"10.1016\/j.peptides.2007.10.006_bib22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/jm00194a009","article-title":"Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor","volume":"22","author":"Bjorkman","year":"1979","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2007.10.006_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1358\/mf.2004.26.9.872564","article-title":"Antiopioid properties of the TYR-MIF-1 family","volume":"26","author":"Bocheva","year":"2004","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib24","first-page":"42","article-title":"Effects of Tyr-MIF's family of peptides on immobilization stress-induced antinociception in rats","volume":"46","author":"Bocheva","year":"2004","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.peptides.2007.10.006_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.peptides.2005.08.009","article-title":"Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord","volume":"27","author":"Botros","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0196-9781(01)00466-1","article-title":"Behavioral and neuroendocrine actions of endomorphin-2","volume":"22","author":"Bujdoso","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib27","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0021-9258(18)33011-4","article-title":"Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis","volume":"258","author":"Burbach","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2007.10.006_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(83)90449-1","article-title":"Oxytocin is a precursor of potent behaviourally active neuropeptides","volume":"94","author":"Burbach","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0006-8993(80)90151-1","article-title":"Oxytocin biotransformation in the rat limbic brain: characterization of peptidase activities and significance in the formation of oxytocin fragments","volume":"202","author":"Burbach","year":"1980","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00433553","article-title":"Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy","volume":"63","author":"Caraceni","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.peptides.2007.10.006_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-5793(74)80315-7","article-title":"Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides","volume":"44","author":"Castensson","year":"1974","journal-title":"FEBS Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib32","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1073\/pnas.68.7.1428","article-title":"Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone","volume":"68","author":"Celis","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2007.10.006_bib33","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0196-9781(98)00110-7","article-title":"Nitric oxide release mediates vasodilator responses to endomorphin 1, but not noceptin\/OFQ, in hindquarters vascular bed of the rat","volume":"19","author":"Champion","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(98)00335-X","article-title":"Endomorphin 1 and 2, the endogenous \u03bc-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat","volume":"63","author":"Champion","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1749-6632.1999.tb07888.x","article-title":"Vasodilator responses to the endomorphin peptides, but not nociceptin\/OFQ, are mediated by nitric oxide release","volume":"897","author":"Champion","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/bbrc.1997.6843","article-title":"The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit","volume":"235","author":"Champion","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2007.10.006_bib37","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0196-9781(97)00210-6","article-title":"Endomorphin 1 and 2, endogenous ligands for the \u03bc-opioid receptor, decreases cardiac output, and total peripheral resistance in the rat","volume":"18","author":"Champion","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib38","doi-asserted-by":"crossref","first-page":"PL409","DOI":"10.1016\/S0024-3205(97)01029-1","article-title":"The endogenous-\u03bc-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat","volume":"61","author":"Champion","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0196-9781(98)00026-6","article-title":"Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse","volume":"19","author":"Champion","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0196-9781(03)00078-0","article-title":"Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats","volume":"24","author":"Chen","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0196-9781(85)90036-1","article-title":"Mesolimbic and striatal dopamine receptor supersensitivity: prophylactic and reversal effects of l-prolyl-l-leucyl-glycinamide (PLG)","volume":"6","author":"Chiu","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0196-9781(81)80019-8","article-title":"Effect of l-prolyl-l-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine\/neuroleptic receptor bindings","volume":"2","author":"Chiu","year":"1981","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib43","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.6117947","article-title":"Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by l-prolyl-l-leucyl-glycinamide","volume":"214","author":"Chiu","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.peptides.2007.10.006_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0278-5846(83)90056-8","article-title":"Are the pharmacological effects of L-prolyl-L-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?","volume":"7","author":"Chiu","year":"1983","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.peptides.2007.10.006_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0306-4522(99)00171-2","article-title":"Endomorphin-1 and endomorphin-2, endogenous ligands for the mu-opioid receptor, inhibit electrical activity of rat rostral ventrolateral medulla neurons in vitro","volume":"93","author":"Chu","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2007.10.006_bib46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0196-9781(99)00060-1","article-title":"Modulatory effects of PLG and its peptodimimetics on haloperidol-induced catalepsy in rats","volume":"20","author":"Costain","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0091-3057(76)90333-6","article-title":"MIF, TRH, and simian social and motor behavior","volume":"5","author":"Crowley","year":"1976","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0304-3959(01)00338-4","article-title":"Antinociceptive effect of continuous intrathecal administration of endomorphin-1","volume":"94","author":"Csullog","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.peptides.2007.10.006_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0024-3205(98)00048-4","article-title":"Endomorphin 1 and 2, endogenous \u03bc-opioid agonists, decrease systemic arterial pressure in the rat","volume":"62","author":"Czapla","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib50","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1164\/ajrccm.162.3.9911102","article-title":"Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine","volume":"162","author":"Czapla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.peptides.2007.10.006_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2005.08.020","article-title":"Reduced suppression of CO2-induced ventilatory stimulation by endomorphins relative to morphine","volume":"1059","author":"Czapla","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib52","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0196-9781(99)00152-7","article-title":"Effects of neonatal treatment with Tyr-MIF-1 and naloxone on the long-term body weight gain induced by repeated postnatal stressful stimuli","volume":"20","author":"D\u2019Amore","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0196-9781(90)90054-9","article-title":"MIF-1 can accelerate neuromotor, EEG and behavioral development in mice","volume":"11","author":"D\u2019Amore","year":"1990","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0196-9781(80)90006-6","article-title":"Opiate receptor antagonism by l-prolyl-l-leucyl-glycinamide, MIF-I","volume":"1","author":"Dickinson","year":"1980","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.2042-7158.1982.tb04721.x","article-title":"A comparison of the effects of Pro-Leu-Gly NH2 and l-leucine on tremorine-induced tremor and rigidity in rats","volume":"34","author":"Dickinson","year":"1982","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/joe.0.0640243","article-title":"Distribution of radioactivity in the organs of the rat and mouse after injection of l-(3H)prolyl-l-leucyl-glycinamide","volume":"64","author":"Dupont","year":"1975","journal-title":"J Endocrinol"},{"key":"10.1016\/j.peptides.2007.10.006_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1974.01760070047007","article-title":"Melanocyte-stimulating hormone-release inhibiting hormone as an anti-depressant: a pilot study","volume":"30","author":"Ehrensing","year":"1974","journal-title":"Arch Gen Psychiat"},{"key":"10.1016\/j.peptides.2007.10.006_bib58","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/ajp.135.5.562","article-title":"Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression","volume":"135","author":"Ehrensing","year":"1978","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.peptides.2007.10.006_bib59","first-page":"303","article-title":"Melanocyte-stimulating hormone release-inhibiting factor-I and tardive dyskinesia","volume":"38","author":"Ehrensing","year":"1977","journal-title":"Dis Nerv Syst"},{"key":"10.1016\/j.peptides.2007.10.006_bib60","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0091-3057(84)80083-0","article-title":"Antagonism of morphine analgesia by prolyl-leucyl-glycinamide (MIF-1) in humans","volume":"21","author":"Ehrensing","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib61","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-0327(94)90098-1","article-title":"Improvement in major depression after low subcutaneous doses of MIF-1","volume":"31","author":"Ehrensing","year":"1994","journal-title":"J Affect Disord"},{"key":"10.1016\/j.peptides.2007.10.006_bib62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0091-3057(82)90358-6","article-title":"Similar antagonism of morphine analgesia by MIF-1 and naloxone in Carassius auratus","volume":"17","author":"Ehrensing","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib63","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0196-9781(92)90165-Y","article-title":"Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1)","volume":"13","author":"Erchegyi","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib64","first-page":"31","article-title":"Structure\u2013activity relationship of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1","volume":"6","author":"Erchegyi","year":"1993","journal-title":"Pept Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0327(99)00187-1","article-title":"A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression","volume":"61","author":"Feighner","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.peptides.2007.10.006_bib66","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00004850-200111000-00005","article-title":"Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression","volume":"16","author":"Feighner","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S1461145703003481","article-title":"Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatment","volume":"6","author":"Feighner","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib68","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.npp.1301149","article-title":"Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice","volume":"32","author":"Fichna","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.peptides.2007.10.006_bib69","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.peptides.2004.09.008","article-title":"Characterization of the [125I]endomorphin-2 binding sites in the MCF7 breast cancer cell line","volume":"26","author":"Fichna","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib70","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000114633","article-title":"Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrome","volume":"12","author":"Fischer","year":"1974","journal-title":"Eur Neurol"},{"key":"10.1016\/j.peptides.2007.10.006_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/jm050644n","article-title":"Design and synthesis of photoaffinity-labeling ligands of the l-prolyl-l-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor","volume":"49","author":"Fisher","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2007.10.006_bib72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1254\/jjp.79.231","article-title":"Effects of Tyr-MIF-1 on stress-induced analgesia and the blockade of development of morphine tolerance by stress in mice","volume":"79","author":"Fukunaga","year":"1999","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib73","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0196-9781(85)90435-8","article-title":"MIF-1 antagonizes warm-, but not cold-water stress-induced analgesia: dissociation from immobility","volume":"6","author":"Galina","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib74","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1476-5381.1987.tb11219.x","article-title":"Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia","volume":"90","author":"Galina","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib75","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0304-3940(88)90527-7","article-title":"Differential activity of the endogenous antiopiate Tyr-MIF-1 after various intensities of stress","volume":"84","author":"Galina","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib76","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0196-9781(99)00127-8","article-title":"The effect of halogenation on blood\u2013brain barrier permeability of a novel peptide drug","volume":"20","author":"Gentry","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(95)00823-3","article-title":"Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by \u03b12-adrenoceptors","volume":"298","author":"Gergen","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(96)00656-5","article-title":"Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist\/mu1-opioid receptor antagonist","volume":"316","author":"Gergen","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib79","series-title":"Central nervous system effects of hypothalamic hormones and other peptides","first-page":"415","article-title":"Clinical utilization of MIF-1","author":"Gerstenbrand","year":"1979"},{"key":"10.1016\/j.peptides.2007.10.006_bib80","first-page":"822","article-title":"[Infusion therapy with mif (melanocyte inhibiting factor) in Parkinson's disease (author's transl)]","volume":"87","author":"Gerstenbrand","year":"1975","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.peptides.2007.10.006_bib81","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/jn.00336.2007","article-title":"Endomorphin-1 modulates intrinsic inhibition in the dorsal vagal complex","volume":"98","author":"Glatzer","year":"2007","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.peptides.2007.10.006_bib82","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1152\/jn.00429.2004","article-title":"Modulation of synaptic transmission in the rat nucleus of the solitary tract by endomorphin-1","volume":"93","author":"Glatzer","year":"2005","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.peptides.2007.10.006_bib83","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)37681-5","article-title":"Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain","volume":"286","author":"Goldberg","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2007.10.006_bib84","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0014-5793(98)01362-3","article-title":"Endomorphins fully activate a cloned human mu opioid receptor","volume":"439","author":"Gong","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib85","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0091-3057(91)90278-A","article-title":"Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat","volume":"38","author":"Gorzalka","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib86","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/jcem-59-1-127","article-title":"Presence of delta-sleep-inducing peptide-like material in human milk","volume":"59","author":"Graf","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.peptides.2007.10.006_bib87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0304-3940(02)00201-X","article-title":"Comparison of the effect of intrathecal endomorphin-1 and endomorphin-2 on spinal cord excitability in rats","volume":"324","author":"Grass","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0361-9230(94)00171-V","article-title":"Enhanced isolation of Tyr-MIF-1 from fresh human brain cortex.","volume":"36","author":"Hackler","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0143-4179(93)90080-T","article-title":"Isolation of Tyr-W-MIF-1 from bovine hypothalami","volume":"24","author":"Hackler","year":"1993","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib90","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0196-9781(94)90056-6","article-title":"Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2)","volume":"15","author":"Hackler","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib91","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0196-9781(97)00259-3","article-title":"Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex","volume":"18","author":"Hackler","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib92","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0196-9781(94)90009-4","article-title":"Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia","volume":"15","author":"Hagan","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib93","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3940(99)00670-9","article-title":"Endomorphin-1 mediates 2Hz but not 100Hz electroacupuncture analgesia in the rat","volume":"274","author":"Han","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-3940(99)00826-5","article-title":"Isobolographic analysis of interaction between spinal endomorphin-1, a newly isolated endogenous opioid peptide, and lidocaine in the rat formalin test","volume":"276","author":"Hao","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib95","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/0091-3057(86)90521-6","article-title":"Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats","volume":"24","author":"Hara","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib96","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/sj.bjp.0702798","article-title":"The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant mu-opioid receptors and SH-SY5Y cells","volume":"128","author":"Harrison","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib97","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0196-9781(98)00022-9","article-title":"Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes","volume":"19","author":"Harrison","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib98","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-3565(24)37248-9","article-title":"Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells","volume":"284","author":"Harrison","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2007.10.006_bib99","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-3806(93)90025-6","article-title":"Effects of neonatal treatment with Tyr-MIF-1, morphiceptin and morphine on development, tail flick, and blood\u2013brain barrier transport","volume":"75","author":"Harrison","year":"1993","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(95)00473-X","article-title":"Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10\u201316), like antidepressants, antagonize melatonin-induced behavioural changes in rats","volume":"284","author":"Hatta","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib101","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/jps.10202","article-title":"Effect of guanidino modification and proline substitution on the in vitro stability and blood\u2013brain barrier permeability of endomorphin II","volume":"91","author":"Hau","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib102","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0361-9230(83)90008-4","article-title":"Tyr-MIF-l affects passive avoidance behavior but not motor activity in rats","volume":"11","author":"Hayashi","year":"1983","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib103","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-7793.1998.071bu.x","article-title":"Endomorphins inhibit high-threshold Ca2+ channel currents in rodent NG108-15 cells overexpressing \u03bc-opioid receptors","volume":"507","author":"Higashida","year":"1998","journal-title":"J Physiol"},{"key":"10.1016\/j.peptides.2007.10.006_bib104","first-page":"59","article-title":"Social recognition in male rats: age differences and modulation by MIF-1 and alaptide","volume":"40","author":"Hlinak","year":"1991","journal-title":"Physiol Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1567-5769(02)00007-3","article-title":"Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products","volume":"2","author":"Horowitz","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib106","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/S0021-9258(18)94157-8","article-title":"Isolation of tyrosine-melanocyte-stimulating hormone release-inhibiting factor 1 from bovine brain tissue","volume":"264","author":"Horvath","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2007.10.006_bib107","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-3011.1990.tb00979.x","article-title":"Evidence for presence of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in human brain cortex","volume":"36","author":"Horvath","year":"1990","journal-title":"Int J Peptide Protein Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib108","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/S0024-3205(99)00532-9","article-title":"Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats","volume":"65","author":"Horvath","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib109","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(98)00117-4","article-title":"Endomorphin-2 and endomorphin-2 are partial agonists at the human \u03bc-opioid receptor","volume":"346","author":"Hosohata","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.peptides.2004.02.009","article-title":"Supraspinal anti-allodynic and rewarding effects of endomorphins in rats","volume":"25","author":"Huang","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib111","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2005.10.039","article-title":"The reciprocal connections of endomorphin 1- and endomorphin 2-containing neurons between the hypothalamus and nucleus tractus solitarii in the rat","volume":"138","author":"Hui","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2007.10.006_bib112","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0091-3057(74)90141-5","article-title":"Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice","volume":"2","author":"Huidobro-Toro","year":"1974","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-3057(75)90153-7","article-title":"Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II","volume":"3","author":"Huidobro-Toro","year":"1975","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib114","series-title":"Psychopharmacology: a generation of progress","first-page":"729","article-title":"Effects of hormones on computer-analyzed human electroencephalogram","author":"Itil","year":"1978"},{"key":"10.1016\/j.peptides.2007.10.006_bib115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.peptides.2005.06.015","article-title":"Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino acids","volume":"27","author":"Janecka","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib116","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00063030-200620030-00003","article-title":"Endomorphins as agents for the treatment of chronic inflammatory disease","volume":"20","author":"Jessop","year":"2006","journal-title":"BioDrugs"},{"key":"10.1016\/j.peptides.2007.10.006_bib117","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-5728(99)00216-7","article-title":"Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues","volume":"106","author":"Jessop","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.peptides.2007.10.006_bib118","series-title":"The first Chinese international bioactive neuropeptide conference","first-page":"23","article-title":"Endomorphins in the immune system: distribution and anti-inflammatory functions","author":"Jessop","year":"2007"},{"key":"10.1016\/j.peptides.2007.10.006_bib119","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(00)02537-3","article-title":"Endomorphin-1 and endomorphin-2 induce the expression of c-FOS immunoreactivity in the rat brain","volume":"873","author":"Jiang","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0196-9781(97)00482-8","article-title":"Parallel stimulations of in vitro and in situ [35S]GTPgammaS binding by endomorphin 1 and DAMGO in mouse brains","volume":"19","author":"Kakizawa","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib121","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0361-9230(99)00105-7","article-title":"Multiple direct actions of peptides on the CNS","volume":"50","author":"Kastin","year":"1999","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib122","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0091-3057(84)80017-9","article-title":"Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs","volume":"21","author":"Kastin","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib123","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0304-3940(94)90110-4","article-title":"Extreme stability of Tyr-MIF-1 in CSF","volume":"174","author":"Kastin","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib124","first-page":"1079","article-title":"Preliminary clinical studies with l-prolyl-l-leucyl-glycine amide in Parkinson's disease","volume":"107","author":"Kastin","year":"1972","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.peptides.2007.10.006_bib125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000124722","article-title":"Hypophysectomy increases Tyr-MIF-1-like immunoreactivity in rat plasma","volume":"45","author":"Kastin","year":"1987","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2007.10.006_bib126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0143-4179(95)90076-4","article-title":"Increase in plasma Tyr-MIF-1-like immunoreactivity after hypophysectomy is robust and reversible by corticosterone","volume":"28","author":"Kastin","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib127","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000126403","article-title":"Uptake, content, regulation of plasma concentration, and binding of Tyr-MIF-1 by the adrenals","volume":"57","author":"Kastin","year":"1993","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2007.10.006_bib128","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1159\/000126322","article-title":"Age-and sex-related changes in Tyr-MIF-1-like immunoreactivity in rat plasma","volume":"56","author":"Kastin","year":"1992","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2007.10.006_bib129","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s002210100736","article-title":"Saturable brain-to-blood transport of endomorphins","volume":"139","author":"Kastin","year":"2001","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/dmd.30.3.231","article-title":"Endomorphins, Met-Enkephalin, Tyr-MIF-1, and the P-glycoprotein efflux system","volume":"30","author":"Kastin","year":"2002","journal-title":"Drug Metab Disp"},{"key":"10.1016\/j.peptides.2007.10.006_bib131","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0091-6749(87)80007-6","article-title":"Some principles in the peptide field","volume":"79","author":"Kastin","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.peptides.2007.10.006_bib132","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.8.3.198","article-title":"Immunoreactive plasma concentrations of an endogenous antiopiate are higher in spontaneously hypertensive rats than in Wistar-Kyoto rats","volume":"8","author":"Kastin","year":"1986","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2007.10.006_bib133","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/0196-9781(94)90133-3","article-title":"Delayed degradation of Tyr-MIF-1 in neonatal rat plasma","volume":"15","author":"Kastin","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-2952(97)00376-6","article-title":"Regional differences in the metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria","volume":"55","author":"Kastin","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0006-2952(94)90133-3","article-title":"Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma","volume":"47","author":"Kastin","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib136","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0024-3205(01)01211-5","article-title":"Regional differences in peptide degradation by rat cerebral microvessels: a novel regulatory mechanism for communication between blood and brain","volume":"69","author":"Kastin","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib137","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1046\/j.1471-4159.1995.64041855.x","article-title":"Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate","volume":"64","author":"Kastin","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.peptides.2007.10.006_bib138","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0091-3057(81)90066-6","article-title":"Effects of MIF-1 and three related peptides on reserpine-induced hypothermia in mice","volume":"15","author":"Kastin","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib139","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0361-9230(81)90121-0","article-title":"Radioimmunoassayable N-Tyr-MIF-1-like activity in the rat brain is increased by pinealectomy","volume":"7","author":"Kastin","year":"1981","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib140","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0091-3057(80)90227-0","article-title":"Naloxone-like actions of MIF-1 do not require the presence of the pituitary","volume":"13","author":"Kastin","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib141","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0091-3057(79)90270-3","article-title":"MIF-1's differential actions as an opiate antagonist","volume":"11","author":"Kastin","year":"1979","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib142","series-title":"Endogenous peptides and learning memory processes","first-page":"563","article-title":"Multiple independent actions of neuropeptides on behavior","author":"Kastin","year":"1981"},{"key":"10.1016\/j.peptides.2007.10.006_bib143","unstructured":"Kastin AJ, Pan W. Peptides and hormesis. Crit Rev Toxicol, in press."},{"key":"10.1016\/j.peptides.2007.10.006_bib144","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0091-3057(91)90084-F","article-title":"EEG evidence that morphine and an enkephalin analog cross the blood\u2013brain barrier","volume":"40","author":"Kastin","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib145","first-page":"2931","article-title":"Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-1","volume":"39","author":"Kastin","year":"1980","journal-title":"Fed Proc"},{"key":"10.1016\/j.peptides.2007.10.006_bib146","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0361-9230(89)90187-1","article-title":"Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.","volume":"23","author":"Kastin","year":"1989","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib147","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0091-3057(78)90051-5","article-title":"Enkephalin and other peptides reduce passiveness","volume":"9","author":"Kastin","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib148","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0091-3057(84)80076-3","article-title":"Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test","volume":"21","author":"Kastin","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib149","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0091-3057(85)90112-1","article-title":"Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception","volume":"23","author":"Kastin","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0196-9781(84)90283-3","article-title":"Misleading concepts in the field of brain peptides","volume":"5","author":"Kastin","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib151","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0149-7634(81)90005-1","article-title":"Acute and chronic stress effects on open field activity in the rat: implications for a model of depression","volume":"5","author":"Katz","year":"1981","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.peptides.2007.10.006_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0196-9781(87)90155-0","article-title":"MIF-1 and Tyr-MIF-1 antagonize morphine and opioid but not non-opioid stress-induced analgesia in the snail, Cepaea nemoralis","volume":"8","author":"Kavaliers","year":"1987","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib153","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0006-8993(86)91147-9","article-title":"Inhibitory influences of FMRFamide and PLG on stress-induced opioid analgesia and activity","volume":"372","author":"Kavaliers","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib154","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0196-9781(86)90129-4","article-title":"Inhibitory influences of MIF-1 (PLG) and Tyr-MIF-1 (YPLG) on aggression and defeat-induced analgesia in mice","volume":"7","author":"Kavaliers","year":"1986","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib155","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0024-3205(86)90091-3","article-title":"Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice","volume":"39","author":"Kavaliers","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib156","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0196-9781(92)90038-5","article-title":"Sex differences in the effects of Tyr-MIF-1 on morphine- and stress-induced analgesia","volume":"13","author":"Kavaliers","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib157","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0196-9781(93)90077-T","article-title":"Sex differences in naloxone- and Tyr-MIF-1-induced hypoalgesia","volume":"14","author":"Kavaliers","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib158","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s000110050502","article-title":"Modulation of peripheral inflammation by locally administered endomorphin-1","volume":"48","author":"Khalil","year":"1999","journal-title":"Inflamm Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib159","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/85115","article-title":"Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs","volume":"4","author":"King","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.peptides.2007.10.006_bib160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00431825","article-title":"Habituation of the head-poke response: effects of an amphetamine-barbiturate mixture, PLG, and fenfluramine","volume":"72","author":"Koek","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.peptides.2007.10.006_bib161","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.peptides.2005.02.006","article-title":"Endomorphins interact with tachykinin receptors","volume":"26","author":"Kosson","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib162","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0196-9781(91)90037-P","article-title":"MIF-1 potentiates the action of tricyclic antidepressants in an animal model of depression","volume":"12","author":"Kostowski","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib163","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0361-9230(93)90145-2","article-title":"Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.","volume":"31","author":"Kostrzewa","year":"1993","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib164","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(89)90392-0","article-title":"MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine","volume":"163","author":"Kostrzewa","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib165","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0091-3057(88)90392-9","article-title":"Antiamnesic effects of d-pipecolic acid and analogues of Pro-Leu-Gly-NH2 in rats","volume":"31","author":"Kovacs","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib166","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(84)90095-9","article-title":"Feeding, drinking, urine osmolality in DI brattleboro rats: changes by morphine, naloxone, d-amino acids, prolyl-leucyl-glycinamide (PLG)","volume":"20","author":"Koyuncuoglu","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib167","first-page":"352","article-title":"Naloxone-like protective effect of MIF-1 (Pro-Leu-Gly-NH2) on hemorrhagic shock","volume":"39","author":"Krause","year":"1984","journal-title":"Pharmazie"},{"issue":"Suppl 1","key":"10.1016\/j.peptides.2007.10.006_bib168","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1007\/BF00587781","article-title":"Neuropharmacological studies with thyrotropin releasing hormone (TRH) and other hypothalamic hormones","volume":"297","author":"Kruse","year":"1977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib169","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1523\/JNEUROSCI.4349-05.2006","article-title":"Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain","volume":"26","author":"Labuz","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2007.10.006_bib170","first-page":"259","article-title":"Rapid antidepressant activity of melanocyte-inhibiting factor: a clinical trial","volume":"17","author":"Levy","year":"1982","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.peptides.2007.10.006_bib171","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1742-4658.2006.05150.x","article-title":"Protective effects of endomorphins, endogenous opioid peptides in the brain, on human low density lipoprotein oxidation","volume":"273","author":"Lin","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.peptides.2007.10.006_bib172","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbadis.2003.09.007","article-title":"Endomorphins, endogenous opioid peptides, provide antioxidant defense in the brain against free radical-induced damage","volume":"1639","author":"Lin","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.peptides.2007.10.006_bib173","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0196-9781(89)90134-4","article-title":"Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and \u03b2-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus","volume":"10","author":"Lipa","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib174","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneumeth.2005.06.001","article-title":"A new electrochemical HPLC method for analysis of enkephalins and endomorphins","volume":"150","author":"Lisi","year":"2006","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.peptides.2007.10.006_bib175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.peptides.2004.11.017","article-title":"Cardiovascular effects of endomorphins in alloxan-induced diabetic rats","volume":"26","author":"Liu","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib176","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0361-9230(81)90117-9","article-title":"Mu and delta opiate receptors in rat brain are affected by GTP but not by MIF-1","volume":"7","author":"Luciano","year":"1981","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib177","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(93)91233-I","article-title":"Tyr-MIF-1 precipitates abstinence syndrome in morphine-dependent rats","volume":"610","author":"Malin","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib178","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0196-9781(97)00321-5","article-title":"Protection against MPTP treatment by an analog of Pro-Leu-Gly-NH2 (PLG, MIF-1)","volume":"19","author":"Marcotte","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib179","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0006-8993(99)01755-2","article-title":"Peptide transport system 1 (PTS-1) for Tyr-MIF-1 and Met-enkephalin differs from the receptors for either","volume":"839","author":"Maresh","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib180","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0196-9781(98)00136-3","article-title":"Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers","volume":"19","author":"Martin-Schild","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib181","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/(SICI)1096-9861(19990322)405:4<450::AID-CNE2>3.0.CO;2-#","article-title":"Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent","volume":"405","author":"Martin-Schild","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.peptides.2007.10.006_bib182","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0196-9781(97)00320-3","article-title":"Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord","volume":"18","author":"Martin-Schild","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib183","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/JMN:22:1-2:125","article-title":"Attenuation of knee joint inflammation by peripherally administered endomorphin-1","volume":"22","author":"McDougall","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.peptides.2007.10.006_bib184","first-page":"R1","article-title":"Ca2+ channel inhibition by endomorphins via the cloned mu-opioid receptor expressed in NG108-15 cells","volume":"340","author":"Mima","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0306-4522(99)00298-5","article-title":"The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons\/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice","volume":"94","author":"Mizoguchi","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2007.10.006_bib186","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0306-4522(00)00306-7","article-title":"Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons\/medulla","volume":"100","author":"Mizoguchi","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2007.10.006_bib187","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0143-4179(91)90057-P","article-title":"Effects of melanostatine (MIF-1) on focal potentials in slices of rat brain cortex","volume":"20","author":"Mokrushin","year":"1991","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib188","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1017\/S1461145705006139","article-title":"Efficacy and safety of 30mg\/d and 45mg\/d nemifitide compared to placebo in major depressive disorder","volume":"9","author":"Montgomery","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib189","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-5728(02)00049-8","article-title":"Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain","volume":"126","author":"Mousa","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.peptides.2007.10.006_bib190","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0196-9781(87)90135-5","article-title":"Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide","volume":"8","author":"Mycroft","year":"1987","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib191","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0196-9781(84)90111-6","article-title":"Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse","volume":"5","author":"Mycroft","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib192","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0006-291X(71)80026-8","article-title":"Isolation and structure of hypothalamic MSH release-inhibiting hormone","volume":"43","author":"Nair","year":"1971","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2007.10.006_bib193","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2007.01.068","article-title":"A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors","volume":"563","author":"Nakayama","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib194","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF02255469","article-title":"G protein activation by endomorphins in the mouse periaqueductal gray matter","volume":"7","author":"Narita","year":"2000","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0014-2999(98)00395-1","article-title":"Characterization of endomorphin-1 and -2 on [35S]GTPgammaS binding in the mouse spinal cord","volume":"351","author":"Narita","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib196","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(01)01975-9","article-title":"Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse","volume":"308","author":"Narita","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib197","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1254\/jjp.89.224","article-title":"Endomorphin-induced motivational effect: differential mechanism of endomorphin-1 and endomorphin-2","volume":"89","author":"Narita","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib198","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/bdd.470","article-title":"Comparison of systemic exposure to nemifitide following two methods of subcutaneous administration to healthy volunteers","volume":"26","author":"Nicolau","year":"2005","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.peptides.2007.10.006_bib199","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0143-4179(84)90092-1","article-title":"Neuropeptides and social behavior of rats tested in dyadic encounters","volume":"4","author":"Niesink","year":"1984","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0014-2999(82)90248-5","article-title":"A new behavioral test for antidepressant drugs","volume":"83","author":"Nomura","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib201","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0196-9781(99)00029-7","article-title":"Tyr-W-MIF-1-induced conditioned place preference","volume":"20","author":"Nores","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib202","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0196-9781(80)90014-5","article-title":"MIF-I suppresses deprivation-induced fluid consumption in rats","volume":"1","author":"Olson","year":"1980","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib203","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0196-9781(99)00194-1","article-title":"l-Prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum","volume":"21","author":"Ott","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(99)00308-8","article-title":"Modulation of acetylcholine release from parasympathetic nerves innervating guinea-pig and human trachea by endomorphin-1 and -2","volume":"374","author":"Patel","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.physbeh.2004.08.034","article-title":"Prolyl-leucyl-glycinamide shares some effects with oxytocin but decreases oxytocin levels","volume":"83","author":"Petersson","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib206","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00001756-199802160-00005","article-title":"Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkeys","volume":"9","author":"Pierce","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2007.10.006_bib207","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0891-0618(00)00042-9","article-title":"Immunocytochemical mapping of endomorphin-2-immunoreactivity in rat brain","volume":"18","author":"Pierce","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.peptides.2007.10.006_bib208","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0091-3057(89)90027-0","article-title":"MIF-1 is active in a chronic stress animal model of depression","volume":"32","author":"Pignatiello","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib209","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0091-3057(74)90090-2","article-title":"Oxotremorine antagonism by prolyl-leucyl-glycine amide administered by different routes and with several anticholinergics","volume":"2","author":"Plotnikoff","year":"1974","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib210","first-page":"211","article-title":"Pharmacological studies with a tripeptide, prolyl-leucyl-glycinamide","volume":"211","author":"Plotnikoff","year":"1974","journal-title":"Arch Int Pharm Therap"},{"key":"10.1016\/j.peptides.2007.10.006_bib211","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0024-3205(71)90326-2","article-title":"DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF)","volume":"10","author":"Plotnikoff","year":"1971","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib212","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3181\/00379727-140-36558","article-title":"Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor","volume":"140","author":"Plotnikoff","year":"1972","journal-title":"MIF Proc Soc Exp Biol Med"},{"key":"10.1016\/j.peptides.2007.10.006_bib213","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000122119","article-title":"Deserpidine antagonism by a tripeptide, l-prolyl-l-leucylglycinamide","volume":"11","author":"Plotnikoff","year":"1973","journal-title":"Neuorendocrinology"},{"key":"10.1016\/j.peptides.2007.10.006_bib214","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000122270","article-title":"DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide","volume":"14","author":"Plotnikoff","year":"1974","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2007.10.006_bib215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2007.10.006_bib216","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0361-9230(86)90095-X","article-title":"Binding of Tyr-MIF-1 to isolated brain capillaries","volume":"17","author":"Pretorius","year":"1986","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.peptides.2007.10.006_bib217","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(98)00956-X","article-title":"Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats","volume":"367","author":"Przewlocka","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib218","first-page":"107","article-title":"MIF-1 facilitates passive avoidance retention","volume":"34","author":"Pucilowski","year":"1982","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1016\/j.peptides.2007.10.006_bib219","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-2999(88)90810-2","article-title":"Blockade of brain dopamine receptors antagonizes the anti-immobility effect of MIF-1 and Tyr-MIF-1 in rats","volume":"151","author":"Pulvirenti","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib220","first-page":"229","article-title":"MIF-1 reduces stress-induced eating in rats","volume":"4","author":"Pulvirenti","year":"1988","journal-title":"New Trends Exp Clin Psychiat"},{"key":"10.1016\/j.peptides.2007.10.006_bib221","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(88)90323-1","article-title":"Naloxone, but not Tyr-MIF-1, reduces volitional ethanol drinking in rats: correlation with degree of spontaneous preference","volume":"31","author":"Pulvirenti","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib222","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0196-9781(87)90072-6","article-title":"Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of l-prolyl-l-leucyl-glycinamide (PLG)","volume":"8","author":"Rajakumar","year":"1987","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib223","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000122558","article-title":"The disappearance, excretion, and metabolism of tritiated prolyl-leucyl-glycinamide in man","volume":"16","author":"Redding","year":"1974","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2007.10.006_bib224","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000122121","article-title":"The distribution, half-life, and excretion of 14C and 3H-labeled l-prolyl-l-leucyl-glycinamide in the rat","volume":"11","author":"Redding","year":"1973","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2007.10.006_bib225","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0196-9781(93)90165-D","article-title":"Micropurification and amino acid sequence of beta-casomorphin-8 in milk from a woman with postpartum psychosis","volume":"14","author":"Renlund","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib226","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.regpep.2005.12.004","article-title":"Endomorphin synthesis in rat brain from intracerebroventricularly injected [3H]-Tyr-Pro: a possible biosynthetic route for endomorphins","volume":"134","author":"Ronai","year":"2006","journal-title":"Regul Pept"},{"key":"10.1016\/j.peptides.2007.10.006_bib227","series-title":"Handbook of biologically active peptides","first-page":"1333","article-title":"Endomorphins as endogenous peptides for mu-opioid receptor: their differences in the pharmacological and physiological characters","author":"Sakurada","year":"2006"},{"key":"10.1016\/j.peptides.2007.10.006_bib228","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0196-9781(02)00016-5","article-title":"Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone","volume":"23","author":"Sakurada","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib229","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01238-9","article-title":"Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse","volume":"427","author":"Sakurada","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(00)02770-0","article-title":"Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone","volume":"881","author":"Sakurada","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib231","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(99)00181-8","article-title":"Differential involvement of \u03bc-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception","volume":"372","author":"Sakurada","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib232","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0091-3057(82)90139-3","article-title":"MIF-1 does not act like naloxone in antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog","volume":"17","author":"Sander","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib233","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1440-1681.2002.03637.x","article-title":"Responses to microinjections of endomorphin and nociceptin into the medullary cardiovascular areas","volume":"29","author":"Sapru","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.peptides.2007.10.006_bib234","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0143-4179(96)90068-2","article-title":"Opioid binding profile of morphiceptin. Tyr-MIF-1 and dynorphin-related peptides in rat brain membranes","volume":"30","author":"Sartania","year":"1996","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib235","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/endo-79-4-768","article-title":"Purification of a bovine hypothalamic factor which elevates pituitary MSH levels in rats","volume":"79","author":"Schally","year":"1966","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2007.10.006_bib236","first-page":"1296","article-title":"[The influence of MIF (melanocyte-stimulating hormone-release inhibiting factor) on psychomotor function and mood in parkinsonian patients. Preliminary report (author's transl)]","volume":"28","author":"Schneider","year":"1978","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.peptides.2007.10.006_bib237","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00001756-199804200-00014","article-title":"Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord","volume":"9","author":"Schreff","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2007.10.006_bib238","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0196-9781(82)90055-9","article-title":"Inhibition by l-prolyl-l-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices","volume":"3","author":"Scimonelli","year":"1982","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib239","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.peptides.2003.11.016","article-title":"Immunohistochemical staining of endomorphin 1 and 2 in the immune cells of the spleen","volume":"25","author":"Seale","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib240","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0006-8993(98)01121-4","article-title":"Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV","volume":"815","author":"Shane","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib241","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0196-9781(03)00045-7","article-title":"Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: a model of human tardive dyskinesia","volume":"24","author":"Sharma","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib242","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/0024-3205(87)90291-8","article-title":"Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2 (PLG; MIF-1)","volume":"40","author":"Sheng","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib243","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1471-4159.1998.70041567.x","article-title":"Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors","volume":"70","author":"Sim","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.peptides.2007.10.006_bib244","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0306-4522(01)00228-7","article-title":"Decreases in endomorphin-2-like immunoreactivity concomitant with chronic pain after nerve injury","volume":"105","author":"Smith","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2007.10.006_bib245","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0024-3205(00)00689-5","article-title":"Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice","volume":"67","author":"Soignier","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib246","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00221-003-1774-0","article-title":"Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells","volume":"156","author":"Somogyvari-Vigh","year":"2004","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib247","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1097\/00001756-199709290-00025","article-title":"Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2","volume":"8","author":"Stone","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2007.10.006_bib248","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0024-3205(02)01681-8","article-title":"Endomorphins 1 and 2 reduce relaxant non-adrenergic, non-cholinergic neurotransmission in rat gastric fundus","volume":"71","author":"Storr","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib249","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(75)90124-0","article-title":"Increased acquisition of a complex appetitive task after MSH and MIF","volume":"3","author":"Stratton","year":"1975","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib250","article-title":"Anti-inflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant arthritis","author":"Straub","year":"2007","journal-title":"Rheumatol Arthritis"},{"key":"10.1016\/j.peptides.2007.10.006_bib251","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1254\/jjp.81.264","article-title":"Antinociceptive effect and enzymatic degradation of endomorphin-1 in newborn rat spinal cord","volume":"81","author":"Sugimoto-Watanabe","year":"1999","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib252","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(01)02095-X","article-title":"Changes in brain content of nociceptin\/orphanin FQ and endomorphin 2 in a rat model of neuropathic pain","volume":"311","author":"Sun","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib253","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0196-9781(85)90034-8","article-title":"Prolyl-leucyl-glycinamide reduces aggression and blocks defeat-induced opioid analgesia in mice","volume":"6","author":"Teskey","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib254","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0196-9781(02)00100-6","article-title":"In vitro quantitative study of the degradation of endomorphins","volume":"23","author":"Tomboly","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib255","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(24)35327-3","article-title":"Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse","volume":"292","author":"Tseng","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2007.10.006_bib256","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1097\/00001756-200112040-00024","article-title":"Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice","volume":"12","author":"Ukai","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2007.10.006_bib257","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(02)01760-0","article-title":"Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice","volume":"446","author":"Ukai","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib258","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0196-9781(03)00123-2","article-title":"Endomorphin-1, an endogenous mu-opioid receptor agonist, improves apomorphine-induced impairment of prepulse inhibition in mice","volume":"24","author":"Ukai","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib259","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(00)00179-5","article-title":"Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice","volume":"395","author":"Ukai","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0196-9781(83)90136-5","article-title":"Rapid clinical effectiveness of MIF-I in the treatment of major depressive illness","volume":"4","author":"van der Velde","year":"1983","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib261","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0163-7258(82)90071-7","article-title":"Neurohypophyseal hormones and brain neurochemistry","volume":"19","author":"Versteeg","year":"1983","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.peptides.2007.10.006_bib262","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.brainres.2005.12.102","article-title":"Endomorphin-2 in the medial NTS attenuates the responses to baroreflex activation","volume":"1073\u20131074","author":"Viard","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib263","first-page":"2290","article-title":"MIF analogues. Part II. Dopa potentiation and fluphenazine antagonism","volume":"27","author":"Voith","year":"1977","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.peptides.2007.10.006_bib264","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0006-8993(73)90802-0","article-title":"Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation","volume":"60","author":"Walter","year":"1973","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib265","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1073\/pnas.72.10.4180","article-title":"Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia","volume":"72","author":"Walter","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2007.10.006_bib266","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3181\/00379727-148-38484","article-title":"Significant differences in the degradation of pro-leu-gly-nH2 by human serum and that of other species","volume":"148","author":"Walter","year":"1975","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.peptides.2007.10.006_bib267","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0306-4522(02)00153-7","article-title":"Endomorphin-2 immunoreactivity in the cervical dorsal horn of the rat spinal cord at the electron microscopic level","volume":"113","author":"Wang","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2007.10.006_bib268","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0006-8993(03)02290-X","article-title":"Electron microscopic examination of the endomorphin 2-like immunoreactive neurons in the rat hypothalamus","volume":"969","author":"Wang","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib269","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.peptides.2005.08.010","article-title":"Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice","volume":"27","author":"Watanabe","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib270","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.104.075697","article-title":"A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse","volume":"312","author":"Watanabe","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2007.10.006_bib271","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0006-8993(88)90733-0","article-title":"Analgesic effects of the putative FSH-suppressing gonadal steroid, 3 alpha-hydroxy-4-pregnen-20-one: possible modes of action","volume":"461","author":"Wiebe","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib272","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(99)00613-8","article-title":"Release of endomorphin-2 like substances from the rat spinal cord","volume":"273","author":"Williams","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib273","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0196-9781(00)00340-5","article-title":"Dissociation of analgesic and rewarding effects of endomorphin-1 in rats","volume":"21","author":"Wilson","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib274","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1254\/jjp.78.337","article-title":"Itch-associated response and antinociception induced by intracisternal endomorphins in mice","volume":"78","author":"Yamaguchi","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib275","first-page":"131","article-title":"Opioid and antiopioid actions of Tyr-MIF-1, Tyr-W-MIF-1 and hemorphin-4 on rat locus coeruleus neurons: intracellular recording in vitro","volume":"40","author":"Yang","year":"1997","journal-title":"Chin J Physiol"},{"key":"10.1016\/j.peptides.2007.10.006_bib276","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0196-9781(80)90061-3","article-title":"Interaction of MIF-I or \u03b1-MSH with d-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures","volume":"1","author":"Yehuda","year":"1980","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib277","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/00207458009147596","article-title":"Antagonistic actions of MIF-1 on the hypothermia and hypomotility induced by \u03b2-endorphin or morphine","volume":"11","author":"Yehuda","year":"1980","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.peptides.2007.10.006_bib278","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.peptides.2006.01.016","article-title":"Endomorphin1 and endomorphin2, endogenous potent inhibitors of electrical field stimulation (EFS)-induced cholinergic contractions of rat isolated bronchus","volume":"27","author":"Yu","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib279","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.peptides.2007.01.002","article-title":"In vitro and in vivo characterization of opioid activities of endomorphins analogs with novel constrained C-terminus: evidence for the important role of proper spatial disposition of the third aromatic ring","volume":"28","author":"Yu","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib280","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.peptides.2006.06.002","article-title":"Abnormal modulation of cholinergic neurotransmission by endomorphin 1 and endomorphin 2 in isolated bronchus of type 1 diabetic rats","volume":"27","author":"Yu","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib281","first-page":"254","article-title":"Mu opiate receptor down-regulation by morphine and up-regulation by nolaxone in SH-SY5Y human neuroblastoma cells","volume":"265","author":"Zadina","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2007.10.006_bib282","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the \u03bc-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2007.10.006_bib283","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0196-9781(85)90329-8","article-title":"Interactions between the antiopiate Tyr-MIF-1 and the mu opiate morphiceptin at their respective binding sites in brain","volume":"6","author":"Zadina","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2007.10.006_bib284","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0091-3057(86)90126-7","article-title":"Interactions of Tyr-MIF-1 at opiate receptor sites","volume":"25","author":"Zadina","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib285","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0024-3205(89)90617-6","article-title":"Chronic, but not acute, administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain","volume":"44","author":"Zadina","year":"1989","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib286","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3940(90)90802-G","article-title":"Tyr-MIF-1 binding in brain is not altered by ligands selective for the GABAA\/benzodiazepine receptor","volume":"110","author":"Zadina","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib287","doi-asserted-by":"crossref","first-page":"PL25","DOI":"10.1016\/0024-3205(90)90632-2","article-title":"Hemorphins, cytochrophins, and human \u03b2-casomorphins bind to antiopiate (Tyr-MIF-1) as well as opiate binding sites in rat brain","volume":"47","author":"Zadina","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib288","doi-asserted-by":"crossref","first-page":"PL461","DOI":"10.1016\/0024-3205(94)00533-8","article-title":"Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs","volume":"55","author":"Zadina","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib289","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0304-3940(93)90712-T","article-title":"Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2)","volume":"155","author":"Zadina","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib290","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0024-3205(92)90615-V","article-title":"Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum","volume":"51","author":"Zadina","year":"1992","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2007.10.006_bib291","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0091-3057(82)90119-8","article-title":"Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain","volume":"17","author":"Zadina","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.peptides.2007.10.006_bib292","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(87)90736-0","article-title":"Long-term hyperalgesia by neonatal \u03b2-endorphin and morphiceptin is blocked by neonatal Tyr-MIF-1","volume":"409","author":"Zadina","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2007.10.006_bib293","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(96)12928-1","article-title":"Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to \u03bc1 and \u03bc2 opiate receptors","volume":"215","author":"Zadina","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2007.10.006_bib294","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1474-8673.2007.00394.x","article-title":"Study on the antinociceptive action of Tyr-K-MIF-1, a peptide from the MIF family","volume":"27","author":"Zamfirova","year":"2007","journal-title":"Auton Autacoid Pharmacol"},{"key":"10.1016\/j.peptides.2007.10.006_bib295","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00005176-200108000-00012","article-title":"Beta endorphin concentrations in human milk","volume":"33","author":"Zanardo","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.peptides.2007.10.006_bib296","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0028-3908(83)90100-4","article-title":"Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam","volume":"22","author":"Zetler","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.peptides.2007.10.006_bib297","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/1044-7431(92)90032-W","article-title":"Tyr-MIF-1, but not MIF-1 or morphine, decreases cyclic AMP-dependent protein kinase activity extracted from HeLa cells","volume":"3","author":"Zhang","year":"1992","journal-title":"Mol Cell Neurosci"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978107004044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978107004044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:09:28Z","timestamp":1737522568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978107004044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":297,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0196978107004044"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2007.10.006","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}